Sodium-glucose cotransporter 2 inhibitor plus pioglitazone vs pioglitazone alone in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
Hung-Wei LiaoYi-Ling WuYuh-Mou SueMeng LeeBruce OvbiagelePublished in: Endocrinology, diabetes & metabolism (2018)
Compared to pioglitazone alone, SGLT-2 inhibitor plus pioglitazone improved glycaemic control, reduced body weight and lowered blood pressure, but increased genital tract infection.